(Q34491460)

2 August 2017

0 references

1 reference

title

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

P Glasziou

6

0 references

Rafael Perera

1 reference

ORCID Public Data File 2021

author name string

C Heneghan

1

1 reference

2 August 2017

P Alonso-Coello

2

1 reference

2 August 2017

J M Garcia-Alamino

3

1 reference

2 August 2017

R Perera

4

1 reference

2 August 2017

E Meats

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

367

1 reference

2 August 2017

issue

9508

1 reference

2 August 2017

page(s)

404-411

1 reference

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Anticoagulants for atrial fibrillation: why is the treatment rate so low?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Empowering patients to monitor and manage oral anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Near patient testing in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

State-of-the-art patient self-management for control of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Recommendations for patients undertaking self management of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Systematic review of studies of self-management of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Self‐management of oral anticoagulation: long‐term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968139-7

7 January 2021

10.1016/S0140-6736(06)68139-7

Identifiers

DOI

1 reference

2 August 2017

1 reference